IBL Tool - Digital Library

Digital Library

Journal description

All volumes of the corresponding journal

All issues of the corresponding volume

All articles of the corresponding issues

51 results found

no	title	author	magazine	year	volume	issue	page(s)	type
1	A systematic survey identified methodological issues in studies estimating anchor-based minimal important differences in patient-reported outcomes	Wang, Yuting			142	C	p. 144-151	article
2	Believing in black boxes: machine learning for healthcare does not need explainability to be evidence-based	McCoy, Liam G.			142	C	p. 252-257	article
3	BNT162b2 vaccine effectiveness was marginally affected by the SARS-CoV-2 beta variant in fully vaccinated individuals	Mor, Orna			142	C	p. 38-44	article
4	Causal analyses of existing databases: the importance of understanding what can be achieved with your data before analysis (commentary on Hernán)	Morris, Tim P.			142	C	p. 261-263	article
5	Challenges of evidence synthesis during the 2020 COVID pandemic: a scoping review	Khalil, Hanan			142	C	p. 10-18	article
6	Change in healthcare during Covid-19 pandemic was assessed through observational designs	Corrao, Giovanni			142	C	p. 45-53	article
7	Commentary on controversy and debate 4 paper series: Questionable utility of the relative risk in clinical research	Wells, George A.			142	C	p. 268-270	article
8	Controversy and Debate: Questionable utility of the relative risk in clinical research: Paper 1: A call for change to practice	Doi, Suhail A.			142	C	p. 271-279	article
9	Controversy and Debate: Questionable utility of the relative risk in clinical research: Paper 2: Is the Odds Ratio “portable” in meta-analysis? Time to consider bivariate generalized linear mixed model	Xiao, Mengli			142	C	p. 280-287	article
10	Controversy and Debate : Questionable utility of the relative risk in clinical research: Paper 4 :Odds Ratios are far from “portable” — A call to use realistic models for effect variation in meta-analysis	Xiao, Mengli			142	C	p. 294-304	article
11	Editorial Board				142	C	p. IFC	article
12	Editors' Choice: February 2022	Tovey, David			142	C	p. A6-A7	article
13	Estimates of minimal clinically important improvments vary with the responsiveness of the sample	Ward, Michael M.			142	C	p. 110-118	article
14	Estimating total morbidity burden of COVID-19: relative importance of death and disability	Smith, Maia P.			142	C	p. 54-59	article
15	European non-commercial sponsors showed substantial variation in results reporting to the EU trial registry	Dal-Ré, Rafael			142	C	p. 161-170	article
16	Extensive variability of work participation outcomes measured in randomized controlled trials: a systematic review	Ravinskaya, Margarita			142	C	p. 60-99	article
17	Feasibility of national living guideline methods: The Australian Stroke Guidelines	Hill, Kelvin			142	C	p. 184-193	article
18	GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines	Cuello-Garcia, Carlos A.			142	C	p. 200-208	article
19	Guidelines developed under pressure. The case of the COVID-19 low-quality “rapid” guidelines and potential solutions	Florez, Ivan D.			142	C	p. 194-199	article
20	International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review	Amer, Yasser S.			142	C	p. 333-370	article
21	Interrater reliability of ROB2 – an alternative measure and way of categorization	Loef, Martin			142	C	p. 326-327	article
22	Kappa and AC1/2 statistics: beyond the paradox	Minozzi, Silvia			142	C	p. 328-329	article
23	Let's end “real-world evidence” terminology usage: A study should be identified by its design	Pacheco, Rafael Leite			142	C	p. 249-251	article
24	Methods used to select results to include in meta-analyses of nutrition research: A meta-research study	Kanukula, Raju			142	C	p. 171-183	article
25	Missing data is poorly handled and reported in prediction model studies using machine learning: a literature review	Nijman, SWJ			142	C	p. 218-229	article
26	Missing trials in drug regulatory dossiers may have good reasons, but should be predefined and transparent	Leufkens, Hubert G.			142	C	p. 258-260	article
27	Mortality prediction in intensive care units including premorbid functional status improved performance and internal validity	Moser, André			142	C	p. 230-241	article
28	Prediction models: stepwise development and simultaneous validation is a step back	Heinze, Georg			142	C	p. 330-331	article
29	Reassembling the fragility index: a demonstration of statistical reasoning	Baer, Benjamin R.			142	C	p. 317-318	article
30	Replicability in the context of systematic reviews: A call for a framework with considerations regarding duplication, overlap, and intentionality	Puljak, Livia			142	C	p. 313-314	article
31	Resource use during systematic review production varies widely: a scoping review: authors’ reply	Nussbaumer-Streit, B			142	C	p. 321-322	article
32	Resource use during systematic review production varies widely: a scoping review: response to Nussbaumer-Streit et al.	Morales-Plaza, Cristhian D.			142	C	p. 319-320	article
33	Rethinking Table 1	Horwitz, Ralph I.			142	C	p. 242-245	article
34	Sequential multiple assignment randomized trial studies should report all key components: a systematic review	Bigirumurame, Theophile			142	C	p. 152-160	article
35	Sex and Gender Appraisal Tool-Systematic Reviews-2 and Participation-To-Prevalence Ratio assessed to whom the evidence applies in sepsis reviews	Antequera, A			142	C	p. 119-132	article
36	Small differences in EQ-5D-5L health utility scores were interpreted differently between and within respondents	McClure, Nathan S.			142	C	p. 133-143	article
37	Stepwise model development and simultaneous validation to keep up with clinically relevant and rapidly changing diagnostic techniques	Haalboom, M			142	C	p. 332	article
38	Table of Contents				142	C	p. A2-A5	article
39	The certainty of the evidence in oral health has not improved according to GRADE: a meta-epidemiological study	Seehra, Jadbinder			142	C	p. 29-37	article
40	The difference between evidence-based medicine, evidence-based (clinical) practice, and evidence-based health care	Puljak, Livia			142	C	p. 311-312	article
41	The fragility index should not be used for sample size calculations in clinical trials	Potter, Gail E			142	C	p. 315-316	article
42	The inclusion of outcomes in search strategies for Cochrane Reviews: authors’ reply	Tsujimoto, Yasushi			142	C	p. 324-325	article
43	The inclusion of outcomes in search strategies for Cochrane Reviews: response to Tsujimoto et al	Verbeek, Jos			142	C	p. 323	article
44	The methodological quality was low and conclusions discordant for meta-analyses comparing proximal humerus fracture treatments: a meta-epidemiological study	Sandau, Nicolai			142	C	p. 100-109	article
45	The methodology of a “living” COVID-19 registry development in a clinical context	Arienti, Chiara			142	C	p. 209-217	article
46	The Odds Ratio is “portable” across baseline risk but not the Relative Risk: Time to do away with the log link in binomial regression	Doi, Suhail A.			142	C	p. 288-293	article
47	The use of GRADE approach in Cochrane reviews of TCM was insufficient: a cross-sectional survey	Wang, Qi			142	C	p. 1-9	article
48	Transparency: A central principle underpinning trustworthy guidelines	Ford, Nathan			142	C	p. 246-248	article
49	Tutorial on directed acyclic graphs	Digitale, Jean C.			142	C	p. 264-267	article
50	Use of core outcome sets was low in clinical trials published in major medical journals	Matvienko-Sikar, Karen			142	C	p. 19-28	article
51	Using a stepwise approach to simultaneously develop and validate machine learning based prediction models	Haalboom, M.			142	C	p. 305-310	article

51 results found

Koninklijke Bibliotheek - National Library of the Netherlands